Overview

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.
Phase:
Phase 2
Details
Lead Sponsor:
Akros Pharma Inc.